Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to understand the implementation and impact of a pragmatically-delivered oncology financial navigation program. The main questions it aims to answer are:
Researchers will examine secondary, standard-of-care collected, patient-reported data, electronic medical record data, and qualitative interview data to answer these questions.
Full description
Guided by the RE-AIM Extension for Equitable Sustainability framework, the investigators will use a series of implementation and effectiveness aims to evaluate equitable implementation of oncology financial navigation into routine cancer care delivery. The investigators hypothesize the proposed assessment will identify potential areas to improve implementation of oncology financial navigation, which will result in better financial and clinical outcomes for patients with cancer. The investigators propose a pragmatic, hybrid effectiveness-implementation study to assess outcomes of oncology financial navigation delivered as routine cancer care and collect information on strategies to address implementation barriers. Outcomes will be assessed overall and for inequities by race, residence, and insurance status using the following specific aims:
Aim 1. Track oncology financial navigation implementation strategies and their effect on implementation outcomes
Aim 2. Evaluate oncology financial navigation effectiveness
Aim 3. Assess how implementation strategies were utilized to overcome barriers to oncology financial navigation
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Aim 1:
Inclusion criteria: As oncology financial navigation will be implemented as standard of care, implementation outcomes will be evaluated for:
Exclusion criteria: None.
Aim 2:
Inclusion criteria: This will be a secondary data analysis of patient-reported data routinely collected since 2020, which will include:
Exclusion criteria: None.
Aim 3:
Inclusion criteria:
Exclusion criteria: None.
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Central trial contact
Stacey Ingram, MEd
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal